ENO2 and colorectal carcinoma: Recent evidence was provided that the C-term domain of ENO2, which is not necessary for metabolic activity, activates the MAPK/ERK signaling pathway and thus promotes proliferation and migration of BRAV V600E-mutated CRC cells [129].